Disease-Causing Gut Bacteria Common in Children

Article

A type of bacteria which can cause diarrhea and inhibit growth in children in developing countries has been found in 14 percent of a sample of children in an industrialized country. However, the children had only mild gastrointestinal symptoms or no symptoms at all. Understanding why is the next step for these researchers.

The bacteria, called Enteroaggregative E. coli, can produce persistent diarrhea and inhibit the growth of children in developing countries. These bacteria have also been linked to traveler's diarrhea and are behind large outbreaks of diarrhea in several industrialized countries. One outbreak in Germany in 2011 left 54 people dead, as the bacterial strain produced a particularly potent toxin. However, the bacteria can also reside in the gut of some carriers without producing any symptoms and so researchers are trying to identify which strains of Enteroaggregative E. coli and which other factors, such as nutrition and using antibiotics, result in diarrheal disease.

A team of Danish scientists has investigated the prevalence of the bacteria in the guts of children in daycare in Denmark. In research recently published in Frontiers in Cellular and Infection Microbiology, the team monitored 179 children from ages 0-6 for a full year. In that time, they monitored the presence of the bacteria in the gut of the children, using stool samples, and their parents noted any gastrointestinal symptoms in a questionnaire.

The team found that Enteroaggregative E. coli was highly prevalent, with 14 percent of the children who tested positive for the bacteria at some point during the yearlong study. Of the children who tested positive, 50 percent experienced some gastrointestinal symptoms, but these were mostly mild and the bacteria had no effect on the growth of the children. Numerous strains of Enteroaggregative E. coli were isolated from the children, and of these 35 percent were resistant to several types of antibiotics.

So given that the children who tested positive for Enteroaggregative E. coli did not present with serious symptoms, do we need to be concerned with these bacteria, drug resistant or not? Under normal circumstances, the microbes in the gut keep each other in balance by competing. However, when outside factors disrupt this balance, diarrheal disease can arise. Professor Karen A. Krogfelt, senior author on the study, tells Frontiers Blog that the results are of concern. "In most healthy children the bacteria will not cause harm due to the natural 'colonization resistance' provided by other types of bacteria in the gut. However, a small shift in the balance of the microbes in the gut (due to other treatments or changes in diet), and then the Enteroaggregative E. coli could take over and produce severe symptoms."

As 35 percent of the isolated Enteroaggregative E. coli strains were resistant to multiple antibiotics, treating the children with these antibiotics might have limited effects on the resistant bacteria, while killing many other types of bacteria in the gut. This could effectively kill off the competition, allowing the Enteroaggregative E. coli to take over.

Other factors that affect the ability of the bacteria to cause disease include strain-specific genetic features and the nutritional health of the children, which may explain why the bacteria appear to cause more diarrheal disease in developing countries. The research team hopes to investigate these factors further. Professor Krogfelt advocates using probiotic agents and foods to provide microbial balance in the gut. This is particularly important following a course of antibiotics. The team hopes that anti-bacterial drugs in the future will be more specific and be less disruptive to our gut microbes, making it more difficult for potentially dangerous bacteria, such as Enteroaggregative E. coli, to cause disease.

Source: Frontiers

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content